<qa>  What is the measurable disease defined by?1. Relapsed andor refractory multiple myeloma with measurable disease, as defined by one or both of the following assessed within 14 days prior to initiation of therapy: a. Serum M-protein 0.5 gd; b. Urine Bence-Jones protein 200 mg24 hours. 